[1] Gonzalez-Horta C, Ballinas-Casarrubias L, Sanchez-Ramirez B, et al. A concurrent exposure to arsenic and fluoride from drinking water in Chihuahua, Mexico. International Journal of Environmental Research and Public Health, 2015, 12: 4587-4601
[2] Chouhan S, Flora SJ. Arsenic and fluoride: Two major ground water pollutants. Indian Journal of Experimental Biology, 2010, 48: 666-678
[3] Zhang A-H (张爱华), Sun Z-W (孙志伟). Basis of Toxicology. Beijing: Science Press, 2008: 126 (in Chinese)
[4] Zeng QB, Xu YY, Yu X, et al. The combined effects of fluorine and arsenic on renal function in a Chinese population. Toxicology Research, 2014, 3: 359-366
[5] Zeng Q-B (曾奇兵), Yu X (喻 仙), Yang J (杨鋆), et al. Biological exposure limit in bone metabolism damage induced by co-exposure to fluorine and arsenic from coal burning. Chinese Journal of Endemiology (中华地方病学杂志), 2012, 31(5): 523-525 (in Chinese)
[6] Zeng Q-B (曾奇兵), Liu Y (刘 云), Hong F (洪峰), et al. Determination of damage in bone metabolism caused by co-exposure to fluoride and arsenic using benchmark dose method in Chinese population. Chinese Journal of Public Health (中国公共卫生), 2012, 28(5): 631-632 (in Chinese)
[7] Lerner UH, Ohlsson C. The WNT system: Background and its role in bone. Internal Medicine Journal, 2015, 277: 630-649
[8] Padhi D, Jang G, Stouch B, et al. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. Journal of Bone and Mineral Research, 2011, 26: 19-26
[9] Wang FS, Ko JY, Lin CL, et al. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. Bone, 2007, 40: 485-492
[10] Bodine PV, Stauffer B, Ponce-De-Leon H, et al. A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation. Bone, 2009, 44: 1063-1068
[11] Gopalsamy A, Shi M, Stauffer B, et al. Identification of diarylsulfone sulfonamides as secreted frizzled related protein-1 (sFRP-1) inhibitors. Journal of Medicinal Chemistry, 2008, 51: 7670-7672
[12] Wang W, Xu J, Liu K, et al. Suppression of sclerostin and dickkopf-1 levels in patients with fluorine bone injury. Environmental Toxicology and Pharmacology, 2013, 35: 402-407
[13] Liu XL, Li CC, Liu KJ, et al. The influence of fluoride on the expression of inhibitors of Wnt/beta-catenin signaling pathway in rat skin fibroblast cells. Biological Trace Element Research, 2012, 148: 117-121
[14] Pan L, Shi X, Liu S, et al. Fluoride promotes osteoblastic differentiation through canonical Wnt/beta-catenin signaling pathway. Toxicology Letters, 2014, 225: 34-42
[15] Wang X, Mandal AK, Saito H, et al. Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/beta-catenin signaling pathway. Toxicology and Applied Pharmaco-logy, 2012, 262: 11-21
[16] Zhang Z, Wang X, Cheng S, et al. Reactive oxygen species mediate arsenic induced cell transformation and tumorigenesis through Wnt/beta-catenin pathway in human colorectal adenocarcinoma DLD1 cells. Toxico-logy and Applied Pharmacology, 2011, 256: 114-121
[17] Huang YZ, Qian XC, Wang GQ, et al. Syndrome of endemic arsenism and fluorosis: A clinical study. Chinese Medical Journal, 1992, 105: 586-590
[18] Cadigan KM, Peifer M. Wnt signaling from development to disease: Insights from model systems. Cold Spring Harbor Perspectives in Biology, 2009, 1: a002881, doi: 10.1101/cshperspect.a002881
[19] Jenny A. Planar cell polarity signaling in the Drosophila eye. Current Topics in Developmental Biology, 2010, 93: 189-227
[20] Kohn AD, Moon RT. Wnt and calcium signaling: β-catenin-independent pathways. Cell Calcium, 2005, 38: 439-446
[21] Crump KS. A new method for determining allowable daily intake. Fundamental and Applied Toxicology, 1984, 4: 854-871
[22] Shao B (邵 波), Jin T-Y (金泰廙), Qian H-L (钱海雷), et al. Application of benchmark dose (BMD) in estimating biological exposure limit (BEL). Chinese Journal of Industrial Hygiene and Occupational Diseases (中华劳动卫生职业病杂志), 2006, 24(1): 20-22 (in Chinese)
[23] Filipsson AF, Sand S, Nilsson J, et al. The benchmark dose method: Review of available models, and recommendations for application in health risk assessment. Critical Reviews in Toxicology, 2003, 33: 505-542 |